Coffee Day Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 8:08 pm

Quick Insight

Coffee Day Enterprises Ltd currently trades at a price of 43.0 with a market capitalization of 908 Cr. The company's financial performance shows a negative net profit of -143 Cr, leading to concerns about its profitability. With a low Price-to-Book Value ratio of 0.22x and an Intrinsic Value that needs further analysis, investors should approach with caution. The high level of borrowings at ₹1,373 Cr compared to reserves of 2,379 Cr raises red flags about the company's leverage. Additionally, the Return on Equity (ROE) and Return on Capital Employed (ROCE) stand at 0.89% and 1.13% respectively, indicating inefficiency in utilizing capital. Overall, Coffee Day Enterprises Ltd appears to face significant financial challenges that warrant thorough due diligence before any investment decisions are made.

Competitors of Coffee Day Enterprises Ltd

All Competitor Stocks of Coffee Day Enterprises Ltd

Quarterly Result

Last Updated: August 19, 2025, 9:00 pm

Below is a detailed analysis of the quarterly data for Coffee Day Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 268.00 Cr. (Mar 2025) to 269.00 Cr., marking an increase of 1.00 Cr..
• For Expenses, as of Jun 2025, the value is 237.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 240.00 Cr. (Mar 2025) to 237.00 Cr., marking a decrease of 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 12.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 44.00 Cr., marking a decrease of 16.00 Cr..
• For Interest, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 46.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 22.00 Cr..
• For Depreciation, as of Jun 2025, the value is 28.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 28.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 865.00% (Mar 2025) to 0.00%, marking a decrease of 865.00%.
• For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from -114.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 137.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.33. The value appears strong and on an upward trend. It has increased from -1.56 (Mar 2025) to 1.33, marking an increase of 2.89.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:10 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:32 pm

Below is a detailed analysis of the balance sheet data for Coffee Day Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 211.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 211.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,379.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,645.00 Cr. (Mar 2024) to 2,379.00 Cr., marking a decrease of 266.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,373.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,363.00 Cr. (Mar 2024) to 1,373.00 Cr., marking an increase of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 975.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 883.00 Cr. (Mar 2024) to 975.00 Cr., marking an increase of 92.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,939.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,103.00 Cr. (Mar 2024) to 4,939.00 Cr., marking a decrease of 164.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 553.00 Cr. (Mar 2024) to 516.00 Cr., marking a decrease of 37.00 Cr..
• For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Investments, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 35.00 Cr..
• For Other Assets, as of Mar 2025, the value is 4,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,499.00 Cr. (Mar 2024) to 4,336.00 Cr., marking a decrease of 163.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,939.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,103.00 Cr. (Mar 2024) to 4,939.00 Cr., marking a decrease of 164.00 Cr..

Notably, the Reserves (2,379.00 Cr.) exceed the Borrowings (1,373.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Coffee Day Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -2.75. This value is below the healthy minimum of 5. It has increased from -15.27 (Mar 24) to -2.75, marking an increase of 12.52.
• For Diluted EPS (Rs.), as of Mar 25, the value is -2.75. This value is below the healthy minimum of 5. It has increased from -15.27 (Mar 24) to -2.75, marking an increase of 12.52.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 3. It has increased from -8.28 (Mar 24) to -0.56, marking an increase of 7.72.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.63. It has decreased from 148.14 (Mar 24) to 122.63, marking a decrease of 25.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.63. It has decreased from 148.14 (Mar 24) to 122.63, marking a decrease of 25.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.02. It has increased from 47.96 (Mar 24) to 51.02, marking an increase of 3.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.57. This value is within the healthy range. It has decreased from 12.86 (Mar 24) to 8.57, marking a decrease of 4.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.64. This value is within the healthy range. It has decreased from 6.64 (Mar 24) to 2.64, marking a decrease of 4.00.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 0. It has increased from -17.42 (Mar 24) to -0.29, marking an increase of 17.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 2. It has increased from -14.51 (Mar 24) to -6.50, marking an increase of 8.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.75. This value is below the healthy minimum of 2. It has increased from -15.27 (Mar 24) to -2.75, marking an increase of 12.52.
• For PBDIT Margin (%), as of Mar 25, the value is 16.80. This value is within the healthy range. It has decreased from 26.81 (Mar 24) to 16.80, marking a decrease of 10.01.
• For PBIT Margin (%), as of Mar 25, the value is 5.16. This value is below the healthy minimum of 10. It has decreased from 13.84 (Mar 24) to 5.16, marking a decrease of 8.68.
• For PBT Margin (%), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 10. It has increased from -36.31 (Mar 24) to -0.57, marking an increase of 35.74.
• For Net Profit Margin (%), as of Mar 25, the value is -12.74. This value is below the healthy minimum of 5. It has increased from -30.24 (Mar 24) to -12.74, marking an increase of 17.50.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -5.38. This value is below the healthy minimum of 8. It has increased from -31.82 (Mar 24) to -5.38, marking an increase of 26.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 15. It has increased from -11.28 (Mar 24) to -2.24, marking an increase of 9.04.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 10. It has decreased from 4.11 (Mar 24) to 1.66, marking a decrease of 2.45.
• For Return On Assets (%), as of Mar 25, the value is -1.17. This value is below the healthy minimum of 5. It has increased from -6.31 (Mar 24) to -1.17, marking an increase of 5.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.15, marking an increase of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.40 (Mar 24) to 0.53, marking an increase of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.21. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.31, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 2.29. This value exceeds the healthy maximum of 2. It has increased from 2.15 (Mar 24) to 2.29, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.83. This value exceeds the healthy maximum of 8. It has increased from 13.57 (Mar 24) to 14.83, marking an increase of 1.26.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.65. This value is below the healthy minimum of 3. It has decreased from 9.17 (Mar 24) to 1.65, marking a decrease of 7.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 3. It has decreased from 6.81 (Mar 24) to -0.68, marking a decrease of 7.49.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,072.32. It has decreased from 2,256.07 (Mar 24) to 2,072.32, marking a decrease of 183.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.92, marking a decrease of 0.31.
• For EV / EBITDA (X), as of Mar 25, the value is 11.44. This value is within the healthy range. It has increased from 8.30 (Mar 24) to 11.44, marking an increase of 3.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.54, marking a decrease of 0.50.
• For Price / BV (X), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.22, marking a decrease of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.54, marking a decrease of 0.50.
• For EarningsYield, as of Mar 25, the value is -0.09. This value is below the healthy minimum of 5. It has increased from -0.30 (Mar 24) to -0.09, marking an increase of 0.21.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness